Ensure Your Pradaxa Patients Don't Need the New Antidote, Praxbind

July 2016

You'll hear buzz about the new IV med, Praxbind (PRAKS-bynd, idarucizumab) to reverse life-threatening bleeding caused by Pradaxa.

This is a big deal. We know that vitamin K reverses bleeding due to warfarin...but it doesn't work for the newer oral anticoagulants such as Pradaxa (dabigatran).

Up until now, managing bleeding with Pradaxa and other newer anticoagulants has been limited to stopping the drug, supportive care, and using blood products in the hospital.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Travel Medicine Be Aware Flomax is a Prostate Med in Canada, But a Pain Med in Italy
Med Safety Provide a Calibrated Measuring Device with Liquid Meds
Communication Explain the "Why" to Encourage Patients to Talk Openly
Check Before Substituting Cardizem CD with Tiazac XC
Report Suspected Loperamide Misuse to Canada Vigilance
Cholesterol Store Praluent In Its Original Packaging In The Fridge
Opioids Look Out for Unusual Dosing Patterns With Long-Acting Opioids
Cardiology Ensure Your Pradaxa Patients Don't Need the New Antidote, Praxbind
Insomnia Watch for Patients Picking Up Melatonin With Rx Sleep Meds
Anticoagulants Be Careful with Enoxaparin's SEVEN Strengths
Smoking Give "Vapers" Resources to Quit E-Cigarettes

Ensure Your Pradaxa Patients Don't Need the New Antidote, Praxbind

Practical advice for a better career, with unlimited access to CE

Table of Contents